Numbers of IFN-γ-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 12, 2000, Pages 1181-1183

  Ulrichs, T ^a   Anding, P ^a   Kaufmann, S H E ^a   Munk, M E ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

ESAT 6 antigen; Human IFN ; Human T cells; M. tuberculosis infection; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTERFERON PRODUCTION; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; DRUG MONITORING; FEMALE; HUMANS; INTERFERON TYPE II; MALE; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0034523795     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
2. A 12.7 kb fragment of the Mycobacterium tuberculosis genome is not present in Mycobacterium bovis
3. Differential T cell responses to Mycobacterium tuberculosis ESAT-6 in tuberculosis patients and healthy donors
4. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis
5. A filter immuno-plaque assay for the detection of antibody secreting cells in vitro
6. Mechanisms of anergy in tuberculosis
7. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculosis pleuritis
8. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
9. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen